117 related articles for article (PubMed ID: 38214420)
41. Impaired class II transactivator expression in mice lacking interferon regulatory factor-2.
Xi H; Goodwin B; Shepherd AT; Blanck G
Oncogene; 2001 Jul; 20(31):4219-27. PubMed ID: 11464288
[TBL] [Abstract][Full Text] [Related]
42. Class II transactivator (CIITA) is sufficient for the inducible expression of major histocompatibility complex class II genes.
Chang CH; Fontes JD; Peterlin M; Flavell RA
J Exp Med; 1994 Oct; 180(4):1367-74. PubMed ID: 7931070
[TBL] [Abstract][Full Text] [Related]
43. Genetic and Epigenetic Regulation of the Innate Immune Response to Gout.
de Lima JD; de Paula AGP; Yuasa BS; de Souza Smanioto CC; da Cruz Silva MC; Dos Santos PI; Prado KB; Winter Boldt AB; Braga TT
Immunol Invest; 2023 Apr; 52(3):364-397. PubMed ID: 36745138
[TBL] [Abstract][Full Text] [Related]
44. Identification of distinct regions of 5' flanking DNA that mediate constitutive, IFN-gamma, STAT1, and TGF-beta-regulated expression of the class II transactivator gene.
Piskurich JF; Wang Y; Linhoff MW; White LC; Ting JP
J Immunol; 1998 Jan; 160(1):233-40. PubMed ID: 9551976
[TBL] [Abstract][Full Text] [Related]
45. MHC class II-deficient tumor cell lines with a defective expression of the class II transactivator.
Naves R; Lennon AM; Barbieri G; Reyes L; Puga G; Salas L; Deffrennes V; Rosemblatt M; Fellous M; Charron D; Alcaïde-Loridan C; Bono MR
Int Immunol; 2002 May; 14(5):481-91. PubMed ID: 11978778
[TBL] [Abstract][Full Text] [Related]
46. Mice lacking the MHC class II transactivator (CIITA) show tissue-specific impairment of MHC class II expression.
Chang CH; Guerder S; Hong SC; van Ewijk W; Flavell RA
Immunity; 1996 Feb; 4(2):167-78. PubMed ID: 8624807
[TBL] [Abstract][Full Text] [Related]
47. Forkhead transcription factor FOXO3a mediates interferon-γ-induced MHC II transcription in macrophages.
Wu X; Fan Z; Chen M; Chen Y; Rong D; Cui Z; Yuan Y; Zhuo L; Xu Y
Immunology; 2019 Dec; 158(4):304-313. PubMed ID: 31509237
[TBL] [Abstract][Full Text] [Related]
48. In Primitive Zebrafish, MHC Class II Expression Is Regulated by IFN-γ, IRF1, and Two Forms of CIITA.
Hou J; Chen SN; Gan Z; Li N; Huang L; Huo HJ; Yang YC; Lu Y; Yin Z; Nie P
J Immunol; 2020 May; 204(9):2401-2415. PubMed ID: 32188757
[TBL] [Abstract][Full Text] [Related]
49. Structural and functional characteristics of a dominant-negative isoform of porcine MHC class II transactivator.
Quinn G; Bower R; Dos-Santos Cruz G; Giovino M; Xu Y; Patience C; Schuurman HJ
Eur J Immunogenet; 2003 Aug; 30(4):259-70. PubMed ID: 12919287
[TBL] [Abstract][Full Text] [Related]
50. Nitric oxide and KLF4 protein epigenetically modify class II transactivator to repress major histocompatibility complex II expression during Mycobacterium bovis bacillus Calmette-Guerin infection.
Ghorpade DS; Holla S; Sinha AY; Alagesan SK; Balaji KN
J Biol Chem; 2013 Jul; 288(28):20592-606. PubMed ID: 23733190
[TBL] [Abstract][Full Text] [Related]
51. The HMG-CoA reductase inhibitor simvastatin inhibits IFN-gamma induced MHC class II expression in human vascular endothelial cells.
Kwak B; Mulhaupt F; Veillard N; Pelli G; Mach F
Swiss Med Wkly; 2001 Jan; 131(3-4):41-6. PubMed ID: 11219190
[TBL] [Abstract][Full Text] [Related]
52. Varying functions of specific major histocompatibility class II transactivator promoter III and IV elements in melanoma cell lines.
Goodwin BL; Xi H; Tejiram R; Eason DD; Ghosh N; Wright KL; Nagarajan U; Boss JM; Blanck G
Cell Growth Differ; 2001 Jun; 12(6):327-35. PubMed ID: 11432807
[TBL] [Abstract][Full Text] [Related]
53. Major histocompatibility class II HLA-DR alpha gene expression in thyrocytes: counter regulation by the class II transactivator and the thyroid Y box protein.
Montani V; Taniguchi SI; Shong M; Suzuki K; Ohmori M; Giuliani C; Napolitano G; Saji M; Fiorentino B; Reimold AM; Ting JP; Kohn LD; Singer DS
Endocrinology; 1998 Jan; 139(1):280-9. PubMed ID: 9421426
[TBL] [Abstract][Full Text] [Related]
54. Histone acetylation regulates the cell type specific CIITA promoters, MHC class II expression and antigen presentation in tumor cells.
Chou SD; Khan AN; Magner WJ; Tomasi TB
Int Immunol; 2005 Nov; 17(11):1483-94. PubMed ID: 16210330
[TBL] [Abstract][Full Text] [Related]
55. Regulation of MHC class II expression and antigen processing in murine and human mesenchymal stromal cells by IFN-gamma, TGF-beta, and cell density.
Romieu-Mourez R; François M; Boivin MN; Stagg J; Galipeau J
J Immunol; 2007 Aug; 179(3):1549-58. PubMed ID: 17641021
[TBL] [Abstract][Full Text] [Related]
56. Role of PKCdelta in IFN-gamma-inducible CIITA gene expression.
Kwon MJ; Yao Y; Walter MJ; Holtzman MJ; Chang CH
Mol Immunol; 2007 Apr; 44(11):2841-9. PubMed ID: 17346795
[TBL] [Abstract][Full Text] [Related]
57. Inhibition of IFN-gamma-induced class II transactivator expression by a 19-kDa lipoprotein from Mycobacterium tuberculosis: a potential mechanism for immune evasion.
Pai RK; Convery M; Hamilton TA; Boom WH; Harding CV
J Immunol; 2003 Jul; 171(1):175-84. PubMed ID: 12816996
[TBL] [Abstract][Full Text] [Related]
58. Peroxisome proliferator-activated receptor gamma interacts with CIITA x RFX5 complex to repress type I collagen gene expression.
Xu Y; Farmer SR; Smith BD
J Biol Chem; 2007 Sep; 282(36):26046-56. PubMed ID: 17611194
[TBL] [Abstract][Full Text] [Related]
59. Increased binding of IFN regulating factor 1 mediates the synergistic induction of CIITA by IFN-gamma and tumor necrosis factor-alpha in human thyroid carcinoma cells.
Rahat MA; Chernichovski I; Lahat N
Int Immunol; 2001 Nov; 13(11):1423-32. PubMed ID: 11675374
[TBL] [Abstract][Full Text] [Related]
60. Repression of IFN-gamma induction of class II transactivator: a role for PRDM1/Blimp-1 in regulation of cytokine signaling.
Tooze RM; Stephenson S; Doody GM
J Immunol; 2006 Oct; 177(7):4584-93. PubMed ID: 16982896
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
